These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16232001)

  • 21. Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer.
    Sugano K; Nakamura S; Ando J; Takayama S; Kamata H; Sekiguchi I; Ubukata M; Kodama T; Arai M; Kasumi F; Hirai Y; Ikeda T; Jinno H; Kitajima M; Aoki D; Hirasawa A; Takeda Y; Yazaki K; Fukutomi T; Kinoshita T; Tsunematsu R; Yoshida T; Izumi M; Umezawa S; Yagata H; Komatsu H; Arimori N; Matoba N; Gondo N; Yokoyama S; Miki Y
    Cancer Sci; 2008 Oct; 99(10):1967-76. PubMed ID: 19016756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
    Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
    van Dijk S; Timmermans DR; Meijers-Heijboer H; Tibben A; van Asperen CJ; Otten W
    J Clin Oncol; 2006 Aug; 24(22):3672-7. PubMed ID: 16877736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disparities in BRCA testing: when insurance coverage is not a barrier.
    Olaya W; Esquivel P; Wong JH; Morgan JW; Freeberg A; Roy-Chowdhury S; Lum SS
    Am J Surg; 2009 Oct; 198(4):562-5. PubMed ID: 19800469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.
    Shahedi K; Emanuelsson M; Wiklund F; Gronberg H
    Cancer; 2006 Mar; 106(6):1237-42. PubMed ID: 16475207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevention of hereditary breast cancer.
    Rodriquez E; Domchek SM
    Semin Oncol; 2007 Oct; 34(5):401-5. PubMed ID: 17920894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
    Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Fan I; Tang J; Li S; Zhang S; Shaw PA; Narod SA
    J Natl Cancer Inst; 2006 Dec; 98(23):1694-706. PubMed ID: 17148771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
    Forman AD; Hall MJ
    Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Be ready against cancer, now": direct-to-consumer advertising for genetic testing.
    William-Jones B
    New Genet Soc; 2006 Apr; 25(1):89-107. PubMed ID: 17312631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interest and attitudes of patients, cancer physicians, medical students and cancer researchers towards a spectrum of genetic tests relevant to breast cancer patients.
    Ngoi N; Lee SC; Hartman M; Khin LW; Wong A
    Breast; 2013 Feb; 22(1):47-52. PubMed ID: 22560561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hamilton county physicians' experience with managed care.
    Taslimi MM; Miller PE; Hicks WH
    Tenn Med; 2000 Apr; 93(4):133-5. PubMed ID: 10754803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physicians' opinion for 'new' genetic testing in Japan.
    Ohata T; Tsuchiya A; Watanabe M; Sumida T; Takada F
    J Hum Genet; 2009 Apr; 54(4):203-8. PubMed ID: 19300458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorado family physicians' knowledge of hereditary breast cancer and related practice.
    Mouchawar J; Klein CE; Mullineaux L
    J Cancer Educ; 2001; 16(1):33-7. PubMed ID: 11270897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commercialization of genetic testing services: the FDA, market forces, and biological tarot cards.
    Malinowski MJ; Blatt RJ
    Tulane Law Rev; 1997 Mar; 71(4):1211-312. PubMed ID: 15744901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic testing and pharmacogenomics: issues for determining the impact to healthcare delivery and costs.
    Phillips KA; Veenstra DL; Ramsey SD; Van Bebber SL; Sakowski J
    Am J Manag Care; 2004 Jul; 10(7 Pt 1):425-32. PubMed ID: 15298364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting trust in on-line prescription drug information and impact of trust on behavior following exposure to DTC advertising.
    Huh J; DeLorme DE; Reid LN
    J Health Commun; 2005 Dec; 10(8):711-31. PubMed ID: 16316935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. General practitioner attitudes to direct-to-consumer genetic testing in New Zealand.
    Ram S; Russell B; Gubb M; Taylor R; Butler C; Khan I; Shelling A
    N Z Med J; 2012 Oct; 125(1364):14-26. PubMed ID: 23242394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reading between the lines: direct-to-consumer advertising of genetic testing in the USA.
    Hull SC; Prasad K
    Reprod Health Matters; 2001 Nov; 9(18):44-8. PubMed ID: 11765398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct-to-consumer genetic testing: good, bad or benign?
    Caulfield T; Ries NM; Ray PN; Shuman C; Wilson B
    Clin Genet; 2010 Feb; 77(2):101-5. PubMed ID: 19968666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.